Literature DB >> 27150808

ACFIS: a web server for fragment-based drug discovery.

Ge-Fei Hao1, Wen Jiang1, Yuan-Nong Ye2, Feng-Xu Wu1, Xiao-Lei Zhu1, Feng-Biao Guo3, Guang-Fu Yang4.   

Abstract

In order to foster innovation and improve the effectiveness of drug discovery, there is a considerable interest in exploring unknown 'chemical space' to identify new bioactive compounds with novel and diverse scaffolds. Hence, fragment-based drug discovery (FBDD) was developed rapidly due to its advanced expansive search for 'chemical space', which can lead to a higher hit rate and ligand efficiency (LE). However, computational screening of fragments is always hampered by the promiscuous binding model. In this study, we developed a new web server Auto Core Fragment in silico Screening (ACFIS). It includes three computational modules, PARA_GEN, CORE_GEN and CAND_GEN. ACFIS can generate core fragment structure from the active molecule using fragment deconstruction analysis and perform in silico screening by growing fragments to the junction of core fragment structure. An integrated energy calculation rapidly identifies which fragments fit the binding site of a protein. We constructed a simple interface to enable users to view top-ranking molecules in 2D and the binding mode in 3D for further experimental exploration. This makes the ACFIS a highly valuable tool for drug discovery. The ACFIS web server is free and open to all users at http://chemyang.ccnu.edu.cn/ccb/server/ACFIS/.
© The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27150808      PMCID: PMC4987934          DOI: 10.1093/nar/gkw393

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

1.  A 'rule of three' for fragment-based lead discovery?

Authors:  Miles Congreve; Robin Carr; Chris Murray; Harren Jhoti
Journal:  Drug Discov Today       Date:  2003-10-01       Impact factor: 7.851

2.  The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures.

Authors:  Renxiao Wang; Xueliang Fang; Yipin Lu; Shaomeng Wang
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

3.  Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex.

Authors:  Ge-Fei Hao; Fu Wang; Hui Li; Xiao-Lei Zhu; Wen-Chao Yang; Li-Shar Huang; Jia-Wei Wu; Edward A Berry; Guang-Fu Yang
Journal:  J Am Chem Soc       Date:  2012-06-27       Impact factor: 15.419

4.  VSDocker: a tool for parallel high-throughput virtual screening using AutoDock on Windows-based computer clusters.

Authors:  Nikita D Prakhov; Alexander L Chernorudskiy; Murat R Gainullin
Journal:  Bioinformatics       Date:  2010-04-08       Impact factor: 6.937

5.  The computer program LUDI: a new method for the de novo design of enzyme inhibitors.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

Review 6.  One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade.

Authors:  Bruno O Villoutreix; David Lagorce; Céline M Labbé; Olivier Sperandio; Maria A Miteva
Journal:  Drug Discov Today       Date:  2013-07-03       Impact factor: 7.851

7.  The 'rule of three' for fragment-based drug discovery: where are we now?

Authors:  Harren Jhoti; Glyn Williams; David C Rees; Christopher W Murray
Journal:  Nat Rev Drug Discov       Date:  2013-07-12       Impact factor: 84.694

Review 8.  Computational approaches for fragment-based and de novo design.

Authors:  Kathryn Loving; Ian Alberts; Woody Sherman
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

9.  iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan.

Authors:  Tsung-Ying Tsai; Kai-Wei Chang; Calvin Yu-Chian Chen
Journal:  J Comput Aided Mol Des       Date:  2011-06-07       Impact factor: 3.686

10.  Application of fragment-based drug discovery to membrane proteins: identification of ligands of the integral membrane enzyme DsbB.

Authors:  Virginie Früh; Yunpeng Zhou; Dan Chen; Caroline Loch; Eiso Ab; Yelena N Grinkova; Herman Verheij; Stephen G Sligar; John H Bushweller; Gregg Siegal
Journal:  Chem Biol       Date:  2010-08-27
View more
  7 in total

1.  Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots).

Authors:  Alexander D MacKerell; Sunhwan Jo; Sirish Kaushik Lakkaraju; Christoffer Lind; Wenbo Yu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-01-03       Impact factor: 3.770

Review 2.  Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications.

Authors:  Yuemin Bian; Xiang-Qun Sean Xie
Journal:  AAPS J       Date:  2018-04-09       Impact factor: 4.009

3.  In silico local QSAR modeling of bioconcentration factor of organophosphate pesticides.

Authors:  Purusottam Banjare; Balaji Matore; Jagadish Singh; Partha Pratim Roy
Journal:  In Silico Pharmacol       Date:  2021-04-04

4.  Auto In Silico Ligand Directing Evolution to Facilitate the Rapid and Efficient Discovery of Drug Lead.

Authors:  Fengxu Wu; Linsheng Zhuo; Fan Wang; Wei Huang; Gefei Hao; Guangfu Yang
Journal:  iScience       Date:  2020-05-18

5.  Distribution- and Metabolism-Based Drug Discovery: A Potassium-Competitive Acid Blocker as a Proof of Concept.

Authors:  Ming-Shu Wang; Yi Gong; Lin-Sheng Zhuo; Xing-Xing Shi; Yan-Guang Tian; Chang-Kang Huang; Wei Huang; Guang-Fu Yang
Journal:  Research (Wash D C)       Date:  2022-07-22

6.  Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suite.

Authors:  Anamika Singh Gaur; Lijo John; Nandan Kumar; M Ram Vivek; Selvaraman Nagamani; Hridoy Jyoti Mahanta; G Narahari Sastry
Journal:  Mol Divers       Date:  2022-08-04       Impact factor: 3.364

7.  An in silico drug repositioning workflow for host-based antivirals.

Authors:  Zexu Li; Yingjia Yao; Xiaolong Cheng; Wei Li; Teng Fei
Journal:  STAR Protoc       Date:  2021-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.